BeOne Medicines AG
ONC
$315.07
$4.321.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.49B | 1.48B | 1.40B | 1.32B | 1.11B |
| Total Other Revenue | 26.11M | 21.73M | 17.27M | -- | 8.75M |
| Total Revenue | 1.51B | 1.50B | 1.41B | 1.32B | 1.12B |
| Cost of Revenue | 167.22M | 142.42M | 196.51M | 164.61M | 165.00M |
| Gross Profit | 1.35B | 1.36B | 1.22B | 1.15B | 952.28M |
| SG&A Expenses | 555.10M | 555.29M | 529.00M | 537.91M | 459.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.26B | 1.31B | 1.25B | 1.23B | 1.11B |
| Operating Income | 249.90M | 185.04M | 163.11M | 87.89M | 11.10M |
| Income Before Tax | 259.22M | 149.24M | 147.16M | 99.55M | 20.90M |
| Income Tax Expenses | 31.86M | 82.74M | 22.32M | 5.23M | 19.63M |
| Earnings from Continuing Operations | 227.36M | 66.50M | 124.84M | 94.32M | 1.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 227.36M | 66.50M | 124.84M | 94.32M | 1.27M |
| EBIT | 249.90M | 185.04M | 163.11M | 87.89M | 11.10M |
| EBITDA | 289.30M | 219.47M | 198.86M | 117.75M | 42.73M |
| EPS Basic | 26.64 | 7.81 | 14.73 | 11.32 | 0.15 |
| Normalized Basic EPS | 1.46 | 1.07 | 0.91 | 0.59 | 0.13 |
| EPS Diluted | 25.35 | 6.80 | 13.52 | 10.14 | 0.15 |
| Normalized Diluted EPS | 1.40 | 1.03 | 0.88 | 0.57 | 0.13 |
| Average Basic Shares Outstanding | 110.96M | 110.73M | 110.22M | 108.32M | 106.93M |
| Average Diluted Shares Outstanding | 8.91M | 8.88M | 8.81M | 8.66M | 8.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |